Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma

BACKGROUND/OBJECTIVE: We aimed to explore the prognostic value of regression rate (RR) of plasma Epstein–Barr virus (EBV) DNA after induction chemotherapy (IC) in patients with stages II–IVA nasopharyngeal carcinoma (NPC). METHODS: Eligible patients receiving IC followed by concurrent chemoradiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hao, Chen, Bin-bin, Wang, Xiao-hui, Mo, Yun-Xian, Han, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319726/
https://www.ncbi.nlm.nih.gov/pubmed/34336675
http://dx.doi.org/10.3389/fonc.2021.689593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319726/
https://www.ncbi.nlm.nih.gov/pubmed/34336675
http://dx.doi.org/10.3389/fonc.2021.689593

Ejemplares similares